Numerous cells with very large and irregular nuclei (“monster” cells) have not hitherto been reported in desmoplastic melanoma (DM). Their prognostic significance in melanomas is a matter of debate, although some authors have associated them with more aggressive tumor behavior. We report a mixed DM on the scalp of an 88-year-old woman imitating an atypical fibroxanthoma. Tumor cells stained positive for SOX10, S100, and cyclin D1; BRAF mutation status was negative, and fluorescence in situ hybridization analysis showed copy number gains in 11q13 (cyclin D1) and 6p25 (RREB1), and loss in 6q23 (MYB). Cyclin D1 amplification is associated with poor prognosis in melanoma.
MassiGLeBoitPE. Unusual and bizarre forms of melanoma. In: Massi G, LeBoit PE, eds.Histological Diagnosis of Nevi and Melanoma. 2nd ed. Springer; 2014:589-618.
2.
CotaCSagginiALoraV, et al.Uncommon histopathological variants of malignant melanoma: part 1. Am J Dermatopathol. 2019;41(4):243-263.
3.
BoydASWuHShyrY. Monster cells in malignant melanoma. Am J Dermatopathol. 2005;27(3):208-210.
4.
SidhuHKSidhuJS. Monster cells in malignant melanoma. Am J Dermatopathol. 2006;28(5):462-463.
5.
ChenLLJaimesNBarkerCA, et al.Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825-833.
6.
KacerovskaDMichalMKutznerHRychnovskyJKazakovD. Metastatic desmoplastic malignant melanoma associated with low-grade myofibroblastic sarcoma. Am J Dermatopathol. 2009;31(5):490-494.
7.
KiuruMMcDermottGBergerMHalpernACBusamKJ. Desmoplastic melanoma with sarcomatoid dedifferentiation. Am J Surg Pathol. 2014;38(6):864-870.
8.
Siong-See LeeJKossardS. Atypical fibroxanthoma-like melanoma with touton-like giant cells. Am J Dermatopathol. 2007;29(5):480-481.
PouryazdanparastPNewmanMMafeeMGuitartJGeramiP. Malignant melanoma with monster cells showing massive cyclin D1 amplification. Am J Dermatopathol. 2009;31(4):402-403.
13.
HawrylukEBBaranJLGeramiPSepehrA. “Monster cell” melanoma with pulmonary metastasis and cyclin D1 amplification. J Cutan Pathol. 2013;40(1):61-65.
14.
TorresEMWilliamsBRAmonA. Aneuploidy: cells losing their balance. Genetics. 2008;179(2):737-746.
15.
SaridakiZPapadatos-PastosDTzardiM, et al.BRAF Mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome. Br J Cancer. 2010;102(12):1762-1768.
16.
RoyPGPrattNPurdieCA, et al.High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer. 2009;127(2):355-360.
17.
ShainAHGarridoMBottonT, et al.Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015;47(10):1194-1199.
